BNGO
insider transactionsBionano Genomics, Inc — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·F
CHIEF MEDICAL OFFICER
$20
18 sh · $1.10
Own -3%
-
Other·F
CHIEF OPERATING OFFICER
$22
20 sh · $1.10
Own -2%
-
Other·F
Principal Accounting Officer
$3
3 sh · $1.10
Own -1%
-
Other·F
Holmlin R. Erik KEY
PRESIDENT AND CEO
$56
51 sh · $1.10
Own -3%
-
Other·F
GENERAL COUNSEL
$7
6 sh · $1.10
Own -2%
-
Grant·A
Holmlin R. Erik KEY
PRESIDENT AND CEO
$0
69.5K sh
Own New
-
Grant·A
Principal Accounting Officer
$0
10.9K sh
Own New
-
Grant·A
CHIEF MEDICAL OFFICER
$0
27.7K sh
Own New
-
Grant·A
GENERAL COUNSEL
$0
26.1K sh
Own New
-
Grant·A
CHIEF OPERATING OFFICER
$0
27.7K sh
Own New
-
Other·F
Chief Operating Officer
$240
59 sh · $4.06
Own -6%
-
Other·F
Chief Medical Officer
$207
51 sh · $4.06
Own -7%
-
Other·F
Chief Operating Officer
$240
59 sh · $4.06
Own -6%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Feb 17, 2026 | Chaubey Alka | Other F | 18 | $20 |
| Feb 17, 2026 | OLDAKOWSKI MARK | Other F | 20 | $22 |
| Feb 17, 2026 | Adamchak Mark | Other F | 3 | $3 |
| Feb 17, 2026 | Holmlin R. Erik KEY | Other F | 51 | $56 |
| Feb 17, 2026 | Dixon Jonathan V. | Other F | 6 | $7 |
| Feb 2, 2026 | Holmlin R. Erik KEY | Grant A | 69.5K | $0 |
| Feb 2, 2026 | Adamchak Mark | Grant A | 10.9K | $0 |
| Feb 2, 2026 | Chaubey Alka | Grant A | 27.7K | $0 |
| Feb 2, 2026 | Dixon Jonathan V. | Grant A | 26.1K | $0 |
| Feb 2, 2026 | OLDAKOWSKI MARK | Grant A | 27.7K | $0 |
| Sep 11, 2025 | OLDAKOWSKI MARK | Other F | 59 | $240 |
| Sep 11, 2025 | Chaubey Alka | Other F | 51 | $207 |
| Sep 11, 2025 | OLDAKOWSKI MARK | Other F | 59 | $240 |
About BNGO insider trading
This page tracks insider transactions for Bionano Genomics, Inc (BNGO) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.